Health for All, Hunger for None. That’s what drives us at Bayer.

Joined April 2010
5,023 Photos and videos
May 12
Earlier today, we published our Q1 2026 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made and where we will put our focus for the next 90 days. Find out more: bayer.com/en/investors-overv…
11
10
2,026
May 12
Bayer has reported a solid performance across all divisions for the first quarter and confirmed its currency-adjusted outlook for 2026. Here’s our digital quarterly statement: spr.ly/6018BBt64j
4
4
5
1,475
#News: We intend to acquire Perfuse Therapeutics, a biopharmaceutical company focused on ischemia-induced ocular diseases. Acquisition complements our pharmaceutical pipeline & reinforces our commitment to developing urgently needed therapies for patients: bayer.com/media/en-us/
8
6
13
2,190
Earlier today, we published our Full Year 2025 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made and where we will put our focus for the next 90 days. Find out more: reports.bayer.com/annual-rep…
25
6
29
6,298
Bayer achieved its upgraded full-year targets for 2025 and shared the company’s outlook for 2026. Here’s our digital annual report: spr.ly/6013hfo4d
6
4
17
4,383
Bayer AG retweeted
NEW EPISODE of Long Strange Trip with Bill Anderson, CEO of @Bayer, just dropped. This episode is a master class in going Founder Mode. In 2 years he's torn down and rebuilt how a 160-year-old company operates. I hope you enjoy it. Leave a comment and let me know what struck you most.
18
10
53
11,297
#NEWS: Bayer presented for the first time detailed results of a pivotal Phase III study in secondary stroke prevention at the International Stroke Conference (ISC) 2026. Learn more: bayer.com/media/en-us/
9
4
16
2,671
Bayer AG retweeted
The U.S. Supreme Court today announced that it will review the Durnell Roundup case. The company expects a decision on the merits during the Court’s 2026 session, which ends in June. Link to press release: bayer.com/media/en-us/bayer-…
12
7
22
4,748
Jan 16
#NEWS: The European Commission grants marketing authorization in the EU for an eye medication with long injection intervals for macular edema following retinal vein occlusion (RVO). #RVO affects 28M adults and can cause sudden vision loss.
6
2
6
2,657
12 Dec 2025
#NEWS: The EU Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommends an eye medication with extended dosing intervals for approval in the treatment of macular edema following retinal vein occlusion.
13
2
9
2,764
23 Nov 2025
Exciting #news Bayer announces positive topline results from the international Phase III study. #TeamBayer #HealthForAll #HungerForNone
22
11
28
5,594
19 Nov 2025
#News: The European Commission has approved our new hormone-free treatment option for vasomotor symptoms (VMS; also known as hot flashes) associated with menopause or caused by endocrine therapy for breast cancer.
7
3
9
3,169
12 Nov 2025
Earlier today, we published our Q3 2025 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made and where we will put our focus for the next 90 days: youtube.com/watch?v=q2pqbzNd…
7
6
16
2,455
12 Nov 2025
Following its performance in the first nine months of the year, @Bayer remains well on track and confirmed its 2025 Group outlook. Here’s our news release: bayer.com/media/en-us/2025-0…
4
15
2,173
24 Oct 2025
#News: The U.S. FDA has approved new hormone-free treatment option for menopause. Learn more: bayer.com/media/de/ #TeamBayer #HealthForAll #HungerForNone
4
6
12
2,927
11 Nov 2025
Hola Farter, lamentamos que estés teniendo este problema. ¿Podrías compartir tu información de contacto: nombre, correo electrónico y número de teléfono? Remitiremos tu consulta al departamento correspondiente para brindarte la respuesta más adecuada. Saludos cordiales.
2
2
1,070
11 Nov 2025
¡Hola Farter! Agradecemos tus valiosos comentarios. Si tienes alguna otra duda, ponte en contacto con nuestro equipo local de Consultas Médicas por correo electrónico: informacionmedicalatam@bayer.com para que te ayudemos a encontrar soluciones personalizadas. Saludos cordiales.
1
1,022
6 Nov 2025
#TeamBayer is pleased to announce the appointment of Dr. Judith Hartmann to the Board of Management effective Mar 1, 2026. She will succeed Wolfgang Nickl as CFO on June 1, 2026, following his planned retirement. Press release: bayer.com/media/en-us/dr-jud…
1
2
8
1,919
9 Oct 2025
.@berninger71 discussed with Rose Goslinga from Pula why insurance for smallholder farmers is important. Catch the recording on Linkedin: linkedin.com/events/73770250…
7
1
6
2,500